Welcome to LookChem.com Sign In|Join Free
  • or
3-(TRIFLUOROMETHOXY)BENZAMIDOXIME is a chemical compound that is utilized in the preparation for "one-pot" synthesis of amidoxime.

886500-80-7

Post Buying Request

886500-80-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

886500-80-7 Usage

Uses

Used in Chemical Synthesis Industry:
3-(TRIFLUOROMETHOXY)BENZAMIDOXIME is used as a precursor compound for the "one-pot" synthesis of amidoxime. This method allows for the efficient and streamlined production of amidoxime compounds, which have various applications in different fields.

Check Digit Verification of cas no

The CAS Registry Mumber 886500-80-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,5,0 and 0 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 886500-80:
(8*8)+(7*8)+(6*6)+(5*5)+(4*0)+(3*0)+(2*8)+(1*0)=197
197 % 10 = 7
So 886500-80-7 is a valid CAS Registry Number.

886500-80-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N'-hydroxy-3-(trifluoromethoxy)benzenecarboximidamide

1.2 Other means of identification

Product number -
Other names 3-(Trifluoromethoxy)benzamidoxime

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:886500-80-7 SDS

886500-80-7Relevant academic research and scientific papers

SUBSTITUENT-INCLUDING UREA COMPOUND

-

Paragraph 0444; 0448-0450; 0552-0554, (2021/12/03)

An object of the present invention is to provide a compound that has a specific chemical structure having an activation effect on SIRT6 and is useful as an active component for preventing and treating inflammatory diseases. The present invention relates to a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. (Each symbol in Formula (1) has the same definition as that described in the specification.)

Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-containing pyrazolo[3,4-b]pyridinones as a new series of AMPKɑ1β1γ1 activators

Xiao, Zhihong,Peng, Yajun,Zheng, Bifeng,Chang, Qi,Guo, Yating,Chen, Zhuo,Li, Qianbin,Hu, Gaoyun

, (2021/03/16)

Adenosine monophosphate-activated protein kinase (AMPK) plays a key role in maintaining whole-body homeostasis and has been regarded as a therapeutic target for the treatment of diabetic nephropathy (DN). Herein, a series of 1,2,4-oxadiazole-containing py

One-pot synthesis of amidoxime via Pd-catalyzed cyanation and amidoximation

Yang, Chu-Ting,Han, Jun,Liu, Jun,Gu, Mei,Li, Yi,Wen, Jun,Yu, Hai-Zhu,Hu, Sheng,Wang, Xiaolin

supporting information, p. 2541 - 2545 (2015/04/14)

A novel "one-pot" reaction was developed for the synthesis of aryl or heteroaryl-substituted amidoxime compounds containing various functional groups. Fluorescence titration experiments coupled with theoretical analysis revealed that the steric hindrance and electronic effects of substituents influence the binding ability of the amidoxime compounds to uranyl ions. This journal is

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 886500-80-7